المؤلفون: Zucca LE; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil; Department of Medical Oncology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Morini Matushita MA; Department of Pathology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., da Silva Oliveira RJ; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Scapulatempo-Neto C; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil; Department of Pathology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., de Lima MA; Nucleous of Epidemiology and Statistics, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Ribeiro GG; Department of Pathology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Viana CR; Department of Pathology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil., Cárcano FM; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil; Department of Medical Oncology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil; Barretos School of Health Sciences, Dr. Paulo Prata-FACISB, Barretos, São Paulo, Brazil., Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil; Life and Health Sciences Research Institute (ICVS), Health Sciences School, University of Minho, Braga, Portugal; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal. Electronic address: ruireis.hcb@gmail.com.

المصدر: Urologic oncology [Urol Oncol] 2018 Jan; Vol. 36 (1), pp. 11.e13-11.e21. Date of Electronic Publication: 2017 Oct 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Carcinoma, Renal Cell/*drug therapy , Immunohistochemistry/*methods , Indoles/*therapeutic use , Pyrroles/*therapeutic use , Receptor Protein-Tyrosine Kinases/*metabolism, Antineoplastic Agents/pharmacology ; Carcinoma, Renal Cell/pathology ; Female ; Humans ; Indoles/pharmacology ; Male ; Middle Aged ; Neoplasm Metastasis ; Pyrroles/pharmacology ; Sunitinib ; Treatment Outcome